ATLASSpruce Biosciences (SPRB) earnings date: Nov 9, 2026
Spruce Biosciences (SPRB) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026. Analysts expect EPS of -$5.76.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SPRB
| Last price | $45.10 (-2.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.8% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Spruce Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Spruce Biosciences reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Spruce Biosciences. You can switch it off at any time.
Alert me before SPRB reportsFree to start. Creating an account takes under a minute.
Notify me when Spruce Biosciences reports
Track SPRB free Add Spruce Biosciences to a free ATLAS watchlist and see its next report date in one place.
SPRB earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$5.76 |
| Last report | Aug 12, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +42.2% |
| Average move around a report | ±7.6% (last 4) |
| Sector | Healthcare · Biotechnology |
Spruce Biosciences earnings history: last 4 reports
Spruce Biosciences last reported on Aug 12, 2026: EPS of -$6.68 against an estimate of -$6.12 (-9.2% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$6.12 | -$6.68 | -9.2% | Miss | +7.2% |
| May 13, 2026 | -$6.11 | -$8.94 | -46.3% | Miss | +4.1% |
| Mar 27, 2026 | -$3.78 | -$0.97 | +74.3% | Beat | -15.3% |
| Mar 4, 2026 | $0.06 | $0.15 | +150.0% | Beat | -3.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SPRB
See the fair value, the probability range and the earnings history of Spruce Biosciences on its ATLAS page.
Spruce Biosciences (SPRB) stock analysisPlans from €3.99 a month.
Spruce Biosciences earnings: frequently asked questions
When does Spruce Biosciences (SPRB) report earnings?
Spruce Biosciences is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for SPRB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$5.76 per share (USD). Estimates can change before the report.
How often does SPRB beat earnings estimates?
Of its last 4 reports with a recorded result, Spruce Biosciences beat the EPS estimate 2 times; the average surprise was +42.2%. Past results do not predict the next one.
How much does SPRB move around earnings?
Over its last 4 reports the stock moved an average of 7.6% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Spruce Biosciences beat earnings estimates last quarter?
Spruce Biosciences last reported on Aug 12, 2026: EPS of -$6.68 against an estimate of -$6.12 (-9.2% surprise), a miss.
How much does SPRB usually move in a day?
On a normal trading day the ATLAS model puts SPRB’s one-day range at about ±3.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer